research semaglutide shows — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people with some chronic diseases, even if they have heart issues. ✍️ Health Semaglutide GLP-1 Receptor Agonist Research

Key benefit: Reduces food cravings, especially for high-calorie, high-sugar foods

If these policy shifts are successful, they could dramatically expand obesity drug coverage for millions of Americans

As discussed in this learning program, its usage is expanding in the treatment of various comorbid medical conditions, aimed at reducing overall cardiovascular risk factors

In addition to the positive data surrounding semaglutide, theres similarly good news surrounding the drug tirzepatide, sold under the trade name Mounjaro

Oxidative stress in the RPE, induced by ROS such as hydrogen peroxide, is hypothesized to be an important driving force in the progression of this disease [16]